Literature DB >> 9597964

Coronary artery bypass graft surgery in Newfoundland and Labrador.

G A Fox1, J O'Dea, P S Parfrey.   

Abstract

BACKGROUND: Newfoundland and Labrador, like other health care jurisdictions, is faced with widening gaps between the demands for health care and a strained ability to supply the necessary resources. The authors carried out a study to determine the rates of appropriate and inappropriate coronary artery bypass grafting (CABG) in the province and the waiting times for this surgery.
METHODS: This retrospective cohort study was performed in the tertiary care hospital that receives all referrals for coronary angiography and coronary artery revascularization for Newfoundland and Labrador. By reviewing the hospital records, the authors identified 2 groups of patients: those in whom critical coronary artery disease was diagnosed on the basis of coronary angiography and who were referred for CABG between Apr. 1, 1994, and Mar. 31, 1995, and those who actually underwent the procedure during that period. By applying specific criteria developed by the RAND Corporation, the authors determined the appropriateness and necessity of CABG in each case. They also compared waiting times for CABG with optimal waiting times; as determined by a consensus-based priority score.
RESULTS: A total of 338 patients underwent CABG during the study period. The cases were characterized by multivessel disease and late-stage angina symptoms. Almost all of the patients had high appropriateness scores (7-9), and nearly 95% had high necessity scores (7-9). However, during the study period, the waiting list increased by about 20%, because a total of 391 patients were referred by the weekly cardiovascular surgery conference; the authors identified these and an additional 31 patients as having necessity scores of 7 or more. Only 7 (23%) of 31 patients for whom CABG was considered very urgent underwent surgery within the recommended 24 hours, and only 30 (24%) of the 122 patients for whom CABG was considered urgent underwent surgery within the recommended 72 hours.
INTERPRETATION: These results provide evidence that the cardiac surgery program in Newfoundland and Labrador is performing CABG in patients for whom surgical revascularization is highly appropriate and necessary. Access to CABG is less than ideal, however, since the waiting list continues to expand, and many patients wait beyond the recommended time for surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9597964      PMCID: PMC1229270     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  14 in total

Review 1.  Ethics of queuing for coronary artery bypass grafting in Canada.

Authors:  Jafna L Cox
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

Review 2.  Assessment of priority for coronary revascularisation procedures. Revascularisation Panel and Consensus Methods Group.

Authors:  C D Naylor; R S Baigrie; B S Goldman; A Basinski
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

3.  Practice variations, appropriateness and decision analysis.

Authors:  J R Hampton
Journal:  QJM       Date:  1995-06

4.  Economics of coronary artery bypass grafting.

Authors:  A Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

5.  Coronary artery bypass surgery: risks and benefits, realistic and unrealistic expectations.

Authors:  L D Hillis
Journal:  J Investig Med       Date:  1995-02       Impact factor: 2.895

6.  Appropriateness in health care delivery: definitions, measurement and policy implications.

Authors:  J N Lavis; G M Anderson
Journal:  CMAJ       Date:  1996-02-01       Impact factor: 8.262

7.  The appropriateness of coronary artery bypass graft surgery in academic medical centers. Working Group of the Appropriateness Project of the Academic Medical Center Consortium.

Authors:  L L Leape; L H Hilborne; J S Schwartz; D W Bates; H R Rubin; P Slavin; R E Park; D M Witter; R J Panzer; R H Brook
Journal:  Ann Intern Med       Date:  1996-07-01       Impact factor: 25.391

8.  Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State.

Authors:  E A McGlynn; C D Naylor; G M Anderson; L L Leape; R E Park; L H Hilborne; S J Bernstein; B S Goldman; P W Armstrong; J W Keesey
Journal:  JAMA       Date:  1994-09-28       Impact factor: 56.272

9.  The appropriateness of performing coronary angiography and coronary artery revascularization in a Swedish population.

Authors:  A Bengtson; J Herlitz; T Karlsson; G Brandrup-Wognsen; A Hjalmarson
Journal:  JAMA       Date:  1994-04-27       Impact factor: 56.272

10.  The changing clinical profile of coronary artery bypass graft patients, 1970-89.

Authors:  M Haraphongse; R K Na-Ayudhya; K K Teo; R Williams; K S Bay; E Gelfand; D Modry; J C Callaghan; T Montague
Journal:  Can J Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.223

View more
  5 in total

1.  Waiting lists for health care: a necessary evil?

Authors:  R F Davies
Journal:  CMAJ       Date:  1999-05-18       Impact factor: 8.262

2.  Determinants of waiting time for a routine family physician consultation in southwestern ontario.

Authors:  Amardeep Thind; Cathy Thorpe; Andrea Burt; Moira Stewart; Graham Reid; Stewart Harris; Judith Belle Brown
Journal:  Healthc Policy       Date:  2007-02

3.  Benchmarking the vital risk of waiting for coronary artery bypass surgery in Ontario.

Authors:  C D Naylor; J P Szalai; M Katic
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

4.  Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991-2000.

Authors:  Adrian R Levy; Boris G Sobolev; Robert Hayden; Michael Kiely; J Mark Fitzgerald; Martin T Schechter
Journal:  BMC Health Serv Res       Date:  2005-03-14       Impact factor: 2.655

5.  Survival enhancing indications for coronary artery bypass graft surgery in California.

Authors:  Zhongmin Li; Richard L Kravitz; James P Marcin; Patrick S Romano; David M Rocke; Timothy A Denton; Ralph G Brindis; Jian Dai; Ezra A Amsterdam
Journal:  BMC Health Serv Res       Date:  2008-12-16       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.